EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study

Valentin M Donath iD, Emma Slebsager Ries, Lise Mariegaard, Tina Dam Kristensen, Bjørn H Ebdrup, Gregory P Strauss, Patrick M Fisher iD, Egill Rostrup, Merete Nordentoft, Rikke Hilker, Marianne Melau, Claudi L Bockting und 4 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0331632 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Valentin M Donath und 15 weiteren Autor:innen. Beteiligte Einrichtung: VIRTU Research Group, Mental Health Centre Copenhagen, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Reward, Schizophrenia, Virtual Reality, Virtual Reality Exposure Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danmarks Frie Forskningsfond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In individuals with schizophrenia spectrum disorders (SSD), negative symptoms (NS) are known to be associated with low quality of life, predictive of adverse long-term outcomes, and barriers to relevant life goals such as educational, vocational, and social attainment. As social cognition, processes of reward appraisal, and anticipation are impaired in individuals with SSD, these dysfunctions are likely to be intertwined with the pathogenesis of NS. Despite their debilitating nature, there remains a scarcity of treatment options for NS, as they, unlike positive symptoms, are largely unaffected by pharmacological interventions. Among indications that psychosocial interventions can reduce NS, more robust evidence is warranted for interventions that directly target NS. In light of the recent advances in Virtual Reality-assisted psychotherapy (VRT) for the treatment of positive symptoms in schizophrenia (i.e., paranoia and auditory hallucinations), this randomised, assessor-blind, controlled pilot study sets out to test the feasibility and acceptability of a novel VRT aimed at alleviating NS through targeting social reward learning (ClinicalTrials.gov registration ID: NCT06993831). The study will enrol 30 outpatients from the public mental health services of Greater Copenhagen, Denmark, who will be equally randomised to receive either treatment as usual (TAU) or TAU combined with 10 sessions of individual, VR-assisted psychotherapy. Feasibility and acceptability endpoints will be supplemented by clinical interviews and ecological momentary assessments (EMA) for indications of treatment efficacy regarding positive and negative symptomatology, functional outcome, and quality of life. Additionally, neurobiological and behavioural correlates of the intervention will be explored by magnetic resonance imaging (MRI). This study has been registered at ClinicalTrials.gov (NCT06993831).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RewardSchizophreniaVirtual RealityVirtual Reality Exposure TherapyAdultFemaleHumansMaleMiddle AgedYoung AdultPilot ProjectsQuality of LifeRandomized Controlled Trials as TopicSchizophrenic PsychologyTreatment OutcomeFeasibility Studies

Autor:innen und Institutionen

  • VIRTU Research Group, Mental Health Centre Copenhagen, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.
  • Centre for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Centre Glostrup, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Psychology, University of Georgia, Athens, Georgia, United States of America.
  • Neurobiology Research Unit, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Valentin M Donath, Patrick M Fisher, Karen S Ambrosen

Förderung

  • Danmarks Frie Forskningsfond

Zitieren

APA

Donath, V. M., Ries, E. S., Mariegaard, L., Kristensen, T. D., Ebdrup, B. H., Strauss, G. P., Fisher, P. M., Rostrup, E., Nordentoft, M., Hilker, R., Melau, M., Bockting, C. L., Albert, N., van Bennekom, M. J., Ambrosen, K. S., & Glenthøj, L. B. (2025). Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study. PLOS One. https://doi.org/10.1371/journal.pone.0331632

Vancouver

Donath VM, Ries ES, Mariegaard L, Kristensen TD, Ebdrup BH, Strauss GP, et al. Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study. PLOS One. 2025. doi:10.1371/journal.pone.0331632

BibTeX
@article{Donath2025,
  author = {Donath, Valentin M and Ries, Emma Slebsager and Mariegaard, Lise and Kristensen, Tina Dam and Ebdrup, Bjørn H and Strauss, Gregory P and Fisher, Patrick M and Rostrup, Egill and Nordentoft, Merete and Hilker, Rikke and Melau, Marianne and Bockting, Claudi L and Albert, Nikolai and van Bennekom, Martine J and Ambrosen, Karen S and Glenthøj, Louise Birkedal},
  title = {Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0331632}
}
Kostenlos starten →